510 participants
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-04
- Start Date:
- 2025-03-27
- Completion:
- 2028-06-01
Conditions
- Esophageal Squamous Cell Carcinoma
Interventions
- DRUG
No Results Yet